The purpose of this study is to determine what effects (good and bad) bevacizumab (Avastin)
and docetaxel (Taxotere), used in combination, have on metastatic gastric and esophageal
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Genentech, Inc. Massachusetts General Hospital Sanofi